Suchergebnisse - (Person:"Barbot, Mattia")

PubPharm (6)

1

The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas

enthalten in: International journal of molecular sciences | 2022

von Regazzo, D. | Mondin, A. | Scaroni, C. | +2

2

Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia

enthalten in: Frontiers in endocrinology | 2022

von Barbot, M. | Mazzeo, P. | Lazzara, M. | +2

3

Glucocorticoid excess and COVID-19 disease

enthalten in: Reviews in endocrine & metabolic disorders | 2021

von Guarnotta, V. | Ferrigno, R. | Martino, M. | +7

4

Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency : A prospective proof-of-concept study

enthalten in: Clinical endocrinology | 2018

von Ceccato, F. | Barbot, M. | Lizzul, L. | +6

5

Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

enthalten in: European journal of endocrinology | 2016

von Ceccato, F. | Barbot, M. | Albiger, N. | +8

6

The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing's syndrome : the use of a LC-MS/MS method in routine clinical practice

enthalten in: European journal of endocrinology | 2014

von Ceccato, F. | Antonelli, G. | Barbot, M. | +8

1
[1]